…nsistent safety profile confirm ELA’s suitability for long-term PBC treatment.…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 103 of 2459… was recently withdrawn from the US creating a therapeutic gap. Seladelpar (SEL), approved in 2024 in the US for patients with PBC and an …
…ed Steatotic Liver Disease (MASLD) is recommended in those with Type 2 Diabetes Mellitus, or high-risk obese individuals. There is limited literature on…
…tudies and case series raised concerns about decreased rates of de novo HCC following DAA therapy, particularly in patients with advanced c…
… 95% CI 1.11 to 2.70) were associated with an increased risk of bronchiectasis. In contrast, obesity was inversely associated with the risk of…
… CI 66.4% to 80.0%) and 93% specific (95% CI 88.2% to 95.4%) in OGI detection compared with clinical diagnosis. CT findings associa…
… in leucopenia were slower, with no apparent difference between belimumab and placebo.Conclusion This post hoc analysis of data from five…
…aired t-test with p<0.05 was considered significant.Conclusions Diabetes is associated with increased BM hematopoietic activation even t…
…0%), thiazide (or thiazide-like) diuretic (91%), ACZ (72%), and digoxin (65%); but fewer to oral NaCl (37%), or steroids (20%) (figure …
…essential for treating haematological malignancies, sarcoma and breast cancer. However, these therapies have long been associated with late-o…
…task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special co…
…o the European Society of Cardiology ADD-RS in combination with D-Dimer for investigating patients with suspected AAD.Methods We perfor…